Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06650267 · ClinicalTrials.gov registry record · Phase 2

Substance Misuse and Family Violence Treatment Fathers

A Phase 2 study of Child Abuse and Violence, Domestic, sponsored by Yale University.

Recruiting
Registry status
Phase 2
Development phase
280
Enrollment target
2
Study locations

NCT06650267: Recruiting Phase 2 study of Child Abuse and Violence, Domestic, sponsored by Yale University.

NCT06650267 is a Phase 2 study of Child Abuse and Violence, Domestic that is actively recruiting participants, run by Yale University. The registered enrollment target is 280 participants, below the 3,299-participant average among 19 other Child Abuse trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06650267, a Phase 2 study of Child Abuse and Violence, Domestic, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
Phase 2
Development phase
280 participants
Enrollment target
2
Study locations

Study Summary

This study involves a randomized controlled trial of Fathers for Change (F4C) compared to Individual Drug Counseling (IDC) with a sample of 280 fathers enrolled in substance use (SU) treatment within community or veterans (VA) healthcare settings to (a) demonstrate F4C efficacy compared to IDC in reducing SU and family violence (FV) at end of treatment, 3- and 6-month post-treatment follow-up, and (b) document improved emotion regulation as the mechanism within F4C that results in reduced SU and FV.

Primary Outcome

Self-reported days of substance misuse reported a positive breathalyzer/urine tox screen will be used to create a sum of the number of weeks with use during treatment and at each follow-up period.

Interventions

  • BEHAVIORAL Fathers for Change (F4C)
  • BEHAVIORAL Individual Drug Counseling (IDC)

Study Locations (2)

Connecticut

  • Yale University Child Study Center - New Haven
  • APT Foundation - West Haven

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2025-02-17
Est. Completion 2030-12-31
Phase Phase 2
Yale University

1,492 total trials

What NCT06650267 shows while recruiting

NCT06650267 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 3,299-participant average among 19 other Child Abuse trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Child Abuse appearing as the primary indexed condition, and to 2 interventions - of which Fathers for Change (F4C) is the first listed.

NCT06650267 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT06650267 about?

NCT06650267 is a clinical study titled "Substance Misuse and Family Violence Treatment Fathers". This study involves a randomized controlled trial of Fathers for Change (F4C) compared to Individual Drug Counseling (IDC) with a sample of 280 fathers enrolled in substance use (SU) treatment within community or veterans (VA) healthcare settings to (a) demonstrate F4C efficacy compared to IDC in re...

What is the current status of trial NCT06650267?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 280 participants. The study started on 2025-02-17. Estimated completion is 2030-12-31.

What conditions does trial NCT06650267 study?

This clinical trial studies the following conditions: Child Abuse, Violence, Domestic, Substance Misuse.

What interventions are being tested in trial NCT06650267?

The interventions under investigation include: Fathers for Change (F4C) (BEHAVIORAL), Individual Drug Counseling (IDC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06650267?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06650267 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06650267's enrollment target sits among peer trials

280 12th of 19 higher than 7 of 19 other Child Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Child Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04084730 · 280 participants · Phase 2

    Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • NCT04518657 · 280 participants · NA

    Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis

  • NCT04634916 · 280 participants · NA

    Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • NCT04829617 · 280 participants · NA

    Promoting Well-being and Health in Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06650267, the US trial registry maintained by the National Library of Medicine. NCT06650267 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.